Select Page

Clinical Insights for Diabetes Innovation

Expert consultation for your diabetes care technology and tools.

MDRequest helps you gain a deeper understanding of your product and how it affects doctors, patients, care teams, employers, and insurance companies to maximize overall value.

Improve Usability

Get a clinician’s point of view on ease of use and experience for your audience of patients and care teams who treat diabetes.

Assess Value

Tap into our expertise to evaluate the overall usefulness of your technology and explore how your tool helps teams streamline their care.

Drive Adoption

Our insights as board-certified experts will help you show value and navigate certification processes to promote adoption by pharmaceutical companies, insurances companies, and employers.

Improve Usability

Get a clinician’s point of view on ease of use and experience for your audience of patients and care teams who treat diabetes.

Assess Value

Tap into our expertise to evaluate the overall usefulness of your technology and explore how your tool helps teams streamline their care.

Drive Adoption

Our insights as board-certified experts will help you show value and navigate certification processes to promote adoption by pharmaceutical companies, insurances companies, and employers.

Meet our founder

Jerome S. Fischer, MD
Board Certified Endocrinologist
Former Partner (Retired) Diabetes & Glandular Disease Clinic

For 36 years, Dr. Fischer was a senior partner of the Diabetes & Glandular Disease Clinic, and a founding member of the DGD research center, an endocrine specialty practice. While practicing at Methodist Hospital System, he was involved in creating and implementing diabetes care technology, developing paper forms and protocols evolving into computerized models. Throughout his career, he has focused on the potential of HIT to profoundly impact and improve diabetes care. He has also enjoyed the recent success of the latest ICU program for software intensive insulin decision support.

Currently he is a member of the Glooko advisory board, connected care group at Lilly, and consulting for iSage. He has lectured for various pharmaceutical companies, including Janssen, Lilly, and Amgen.

With his retirement from clinical practice, he is looking forward to continuing to make contributions to diabetes technology by helping to improve the quality and ability for patients and the care team to work together through innovative technology.

Who we work with

Advisory Board Member

Consultant

Clients

Who we work with

Advisory Board Member

CONSULTANT

Clients

Set up a consultation

What type of project is this?

jsfischer@medrequest.com  |  210-410-8472